Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults

Diabetic Medicine

Volumn 24, Issue 8, 2007, Pages 848-854

  Sung, K C ^a   Rhee, E J ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Fasting hyperglycaemia; Glycated haemoglobin; Metabolic syndrome

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; AGED; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; ETHNIC GROUP; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; POPULATION; PRACTICE GUIDELINE; PREDICTION; PREDICTOR VARIABLE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 34447647840     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02146.x     Document Type: Article

References (28)

1. IDF. Diabetes Atlas. 2003. Available at http://www.eatlas.idf.org/ webdata/docs/Atlas%202003-Summary.pdf Last accessed 17 March 2007.
2. Diabetes UK. Diabetes: State of the Nations 2005. Available at http://www.diabetes.org.uk/Documents/Reports/StateOfNations.pdf Last accessed 17 March 2007.
3. Hamman RF. Genetic and environmental determinants of non-insulin- dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992 8 : 287 338.
4. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984 76 : 4 12.
5. Stern MP. Diabetes and cardiovascular disease: the common soil hypothesis. Diabetes 1995 44 : 369 381.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 : 1595 1607.
7. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 14 : 173 194.
8. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999 22 : 233 240.
9. Decode Study Group. Glucose tolerance and cardiovascular mortality: comparision of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001 161 : 397 405.
10. Groot L, Ortho-Melander M. The dysmetabolic syndrome. Intern Med 2001 250 : 105 120.
11. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002 19 : 708 723.
12. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: the Rancho Bernardo Study. Diabetes Care 1996 19 : 450 456.
13. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999 42 : 926 931.
14. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001 322 : 15 18.
15. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM et al. Hemoglobin A1c level and future cardiovas- cular events among women. Arch Intern Med 2004 164 : 757 761.
16. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004 19 : 1175 1180.
17. Magliano DJ, Shaw JE, Zimmet PZ. How to best define the metabolic syndrome. Ann Med 2006 38 : 34 41.
18. Osei K, Rhinesmith S, Gaillard T, Schuster D. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 2003 88 : 4596 4601.
19. List of NGSP Certified Methods. Available at http://www.ngsp.org/prog/ methods.pdf Last accessed 17 March 2007.
20. 1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 2005 6 : 28.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatic model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985 28 : 412 419.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006 29 : S43 S48.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 2752.
24. Alberti KG, Zimmet P, Shaw J IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 : 1059 1062.
25. WHO West Pacific Region. The Asia-Pacific Perspective: Refining Obesity and its Treatment. London : International Obesity Taskforce 2000.
26. 1c determinations. Clin Chem Lab Med 1998 36 : 299 308. Available at http://www.ngsp.org/prog/IFCCstd.pdf Last accessed 17 March 2007.
27. Peterson KP, Pailovich JG, Goldstein D, Little R, England J, Peterson CM. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem 1998 44 : 1951 58.
28. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003 26 : 917 932.